Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Quantifying factors for the success of stratified medicine.
Nat Rev Drug Discov. 2011 Oct 31;10(11):817-33. doi: 10.1038/nrd3557.
Nat Rev Drug Discov. 2011.
PMID: 22037040
Review.
Informing the selection of futility stopping thresholds: case study from a late-phase clinical trial.
Hughes S, Cuffe RL, Lieftucht A, Garrett Nichols W.
Hughes S, et al. Among authors: lieftucht a.
Pharm Stat. 2009 Jan-Mar;8(1):25-37. doi: 10.1002/pst.323.
Pharm Stat. 2009.
PMID: 18383194
Item in Clipboard
Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.
Mt-Isa S, Hallgreen CE, Wang N, Callréus T, Genov G, Hirsch I, Hobbiger SF, Hockley KS, Luciani D, Phillips LD, Quartey G, Sarac SB, Stoeckert I, Tzoulaki I, Micaleff A, Ashby D; IMI-PROTECT benefit-risk participants.
Mt-Isa S, et al.
Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):667-78. doi: 10.1002/pds.3636. Epub 2014 May 13.
Pharmacoepidemiol Drug Saf. 2014.
PMID: 24821575
Review.
Item in Clipboard
Post-Marketing Benefit-Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis.
Ledent E, Lieftucht A, Buyse H, Sugiyama K, Mckenna M, Holl K.
Ledent E, et al. Among authors: lieftucht a.
Drug Saf. 2016 Mar;39(3):219-30. doi: 10.1007/s40264-015-0376-7.
Drug Saf. 2016.
PMID: 26748506
Free PMC article.
Item in Clipboard
Literature review of visual representation of the results of benefit-risk assessments of medicinal products.
Hallgreen CE, Mt-Isa S, Lieftucht A, Phillips LD, Hughes D, Talbot S, Asiimwe A, Downey G, Genov G, Hermann R, Noel R, Peters R, Micaleff A, Tzoulaki I, Ashby D; PROTECT Benefit-Risk group.
Hallgreen CE, et al. Among authors: lieftucht a.
Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):238-50. doi: 10.1002/pds.3880. Epub 2015 Nov 2.
Pharmacoepidemiol Drug Saf. 2016.
PMID: 26521865
Free article.
Review.
Item in Clipboard
Recommendations for benefit-risk assessment methodologies and visual representations.
Hughes D, Waddingham E, Mt-Isa S, Goginsky A, Chan E, Downey GF, Hallgreen CE, Hockley KS, Juhaeri J, Lieftucht A, Metcalf MA, Noel RA, Phillips LD, Ashby D, Micaleff A; PROTECT Benefit-Risk Group.
Hughes D, et al. Among authors: lieftucht a.
Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):251-62. doi: 10.1002/pds.3958. Epub 2016 Jan 22.
Pharmacoepidemiol Drug Saf. 2016.
PMID: 26800458
Free article.
Item in Clipboard
Estimating the burden of serogroup C meningococcal disease in England and Wales.
Davison KL, Ramsay ME, Crowcroft NS, Lieftucht A, Kaczmarski EB, Trotter CL, Gungabissoon U, Begg NT.
Davison KL, et al. Among authors: lieftucht a.
Commun Dis Public Health. 2002 Sep;5(3):213-9.
Commun Dis Public Health. 2002.
PMID: 12434691
Item in Clipboard
Tularemia outbreak investigation in Kosovo: case control and environmental studies.
Reintjes R, Dedushaj I, Gjini A, Jorgensen TR, Cotter B, Lieftucht A, D'Ancona F, Dennis DT, Kosoy MA, Mulliqi-Osmani G, Grunow R, Kalaveshi A, Gashi L, Humolli I.
Reintjes R, et al. Among authors: lieftucht a.
Emerg Infect Dis. 2002 Jan;8(1):69-73.
Emerg Infect Dis. 2002.
PMID: 11749751
Item in Clipboard
Cite
Cite